Multiple Myeloma Rounds ®

Multiple Myeloma Rounds ®

  We are excited to announce the formation of the Multiple Myeloma Rounds®!

Please Join us at one of these Free CME/CE Accredited Dinner Programs in your area!

In 2016, Dr. Agne Paner and her colleagues at several institutions in the Chicago area joined together to form the Chicago Multiple Myeloma Rounds Committee. Their collaborative effort led to the implementation of four Multiple Myeloma Rounds programs that were held in the Chicago area in 2016.

As a result of the success of the Chicago Multiple Myeloma Rounds, the Committee decided to expand the program to other multiple myeloma communities around the country.  

We are pleased that the Multiple Myeloma Rounds program has now grown to include a Committee of 36 multiple myeloma specialists from 24 different institutions who will be implementing the Multiple Myeloma Rounds program in 5 cities across the country!

This program will continue to provide a forum for local healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their multiple myeloma patients.  

The Multiple Myeloma Rounds provides an opportunity for participants to exchange information, network with their colleagues, share best practices and learn the latest information on new therapies and advances in the management of multiple myeloma through interactive case studies presented by experts in the local area.

Please join us at one of the upcoming events! 

The Multiple Myeloma Rounds Program Chairs and Committee Members

Chicago Multiple Myeloma Rounds Founding Chair and CME Course Director: 
Agne Paner, MD Rush University

Chicago Multiple Myeloma Rounds Regional Chairpersons 
(A complete list of all Committee Members can be found on tab at top of page)

Ajay K. Nooka, MD, MPH, FACP Winship Cancer Institute Emory University
Agne Paner, MD Rush University
Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD Moffitt Cancer Center
 Ola Landgren, MD and Neha S. Korde, MD Memorial Sloan Kettering Cancer Center
William Bensinger, MD Swedish Cancer Institute   
              Edward Libby, MD Seattle Cancer Care Alliance 

 logo colors 04 text at bottomsmall           
12 252 LRF Final Logo             Plexus logo 1.28           Rush Logo MasterBrndTransparent                                      


Accreditation Information: 

In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.


Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity provides 2.0 ONCC credit hours. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses. 


This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.

There is no fee for participating in this activity.

Educational Objectives:

1.  Distinguish among the biologic and molecular mechanisms involved in the pathology of MM as it relates to therapeutic targets and treatment selection

2.  Appraise conventional, newly approved, and emerging therapies thathave the potential to enhance clinical outcomes

3.  Identify disease- and therapy-associated adverse events and utilize evidence-based management strategies

4.  Devise optimal evidence-based strategies for individualized treatment

5. Identify limitations and controversies in the standard of care treatment in MM, and how these pertain to individual patient management

Chicago Multiple Myeloma Rounds Committee 

Loyola University Medical Center: 
Kevin Barton, MD
      Patrick Hagen, MD

Advocate Lutheran General Hospital: 
Tulio Rodriguez, MD

Medical College of Wisconsin:
Binod Dhakal, MD
     Parameswaran Hari, MD

Rush University Medical Center:
Agne Paner, MD, (Program Chair) and Parameswaran Venugopal, MD

John H. Stroger, Jr Hospital of Cook County:
David Sumoza, MD    

University of Illinois at Chicago Medical Center:
    Pritesh Patel, MD

University of Chicago Medical Center:
Michael Bishop, MD

Florida Multiple Myeloma Rounds Committee

Moffitt Cancer Center:
    Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD

Los Angeles Committee Members:

Robert Vescio, MD: Los Angeles Multiple Myeloma Rounds Chair: Medical Director, Cedars Sinai Medical Center

Amrita Krishnan, MD: City of Hope Cancer Center

Sarah Larson, MD:  Ronald Reagan UCLA Medical Center

Ann Mohrbacher, MD: Keck Medicine of USC

Date: Wednesday, November 13, 2019
Time: 5:30pm-8:30pm
Location: Brasserie 8 1/2 
9 W. 57th St, New York, NY 10019


5:30-6:15 pm Exhibits/Sign-In/Dinner
6:15 pm: Introduction to Case #1: Non-secretory multiple myeloma
                 Presented by: Liza-Marie Bachier, MD
                                         Nishi Shah, MD
                                            Montifiore Medical Center
6:50 pm: Introduction of Case #2: Management of aggressive plasmablastic myeloma
                        Presented by: Marc Braunstein, MD
                               Crystal Antoine-Pepeljugoski, MD
                               NYU Langone Medical Center
7:30 pm: Introduction of Case #3: Recent updates in AL Amyloidosis therapy
                        Presented by: Divaya Bhutani, MD
                        Columbia University Medical Center
8:15 pm: Closing Remarks/Q&A


NYC/NJ Multiple Myeloma Rounds Committee

Memorial Sloan Kettering Cancer Center: 
       Ola Landgren, MD (Program Chair)

Columbia University Medical Center:
       Suzanne Lentzsch, MD

Hackensack Medical Center: 
        David Siegel, MD, Noa Biran, MD, David Vesole, MD

Memorial Sloan Kettering Cancer Center: 
        Neha S. Korde, MD

Mount Sinai Hospital: 
       Sundar Jagannath, MD, Joshua Richter, MD, Deepu Madduri, MD

Weill Cornell Medical Center: 

       Ruben Niesvizky, MD, Roger N. Pearse, MD, Adriana Rossi, MD, Cara Rosenbaum, MD


Date:Tuesday, November 19, 2019
Time: 5:30pm-8:30pm
Location: Renaissance Seattle Hotel
                  515 Madison St
                  Seattle, WA 98104

Seattle Multiple Myeloma Rounds Committee 

Swedish Cancer Institute
     William Bensinger, MD (CO-CHAIR)

Seattle Cancer Care Alliance/University of Washington
      Edward Libby, MD (CO-CHAIR)

Fred Hutchinson Cancer Center: 
     Damian Green, MD

Swedish Cancer Institute: 
      Ami Batchelder, PA-C

VA Puget Sound Health Care system/University of Washington Medical Center    
     Thomas Chauncey, MD

The Multiple Myeloma Rounds program is proudly endorsed by:
The Leukemia Foundation
The Amyloidosis Foundation

LRF Logo high res    logo colors 04 text at bottomsmall

If your company is interested in exhibiting at any of these events, please contact us at:

E-mail: [email protected]

Phone: 1-866-607-4333

Your Information

Your Name*
Your Email:*
How did you hear about this program?: *

Categories: Symposia

Don't have an account yet? Register Now!

Sign in to your account